Universita’ Vita-salute S. Raffaele

Psychiatric Disorders

Clinical research in major depressive disorder focuses on treatment-resistant illness and the neurobiological factors linked to response to ketamine and electroconvulsive therapy.

  • treatment-resistant depression
  • ketamine
  • electroconvulsive therapy
  • neurochemical response markers

Work in this area centers on identifying clinical and biological features associated with antidepressant response.

Breast Cancer Imaging and Axillary Staging

Research in breast cancer addresses luminal A and lobular subtypes, with emphasis on imaging for axillary lymph node assessment and surgical planning.

  • luminal A breast cancer
  • lobular breast cancer
  • axillary staging
  • molecular imaging

The sponsor is involved in studies evaluating imaging approaches used to detect metastatic involvement in the axilla.

Non-Small Cell Lung Cancer

In non-small cell lung cancer, research is directed toward immune-based treatment strategies and the clinical problem of hyperprogression and early mortality in patients with advanced disease.

  • PD-L1–positive disease
  • immune checkpoint therapy
  • hyperprogression
  • early death

This area reflects interest in outcomes linked to treatment response and resistance in thoracic oncology.

Want to learn more about this study or check if you can participate? Contact us.

Matched clinical trials

  • Study on the Effects of Ketamine and Electroconvulsive Therapy for Patients with Treatment-Resistant Major Depressive Disorder

    Recruiting

    3 1 1
    Italy
  • Study on 18F-FES PET/MRI for Patients with Luminal A and Lobular Breast Cancer to Improve Treatment Decisions

    Recruiting

    2 1 1 1
    Italy
  • Study on the Effects of Ketamine and Electroconvulsive Therapy in Patients with Treatment-Resistant Major Depressive Disorder

    Not yet recruiting

    3 1 1
    Italy
  • Study of cemiplimab with or without chemotherapy for non-small cell lung cancer patients with high PD-L1 levels to reduce rapid disease progression

    Not yet recruiting

    2 1 1 1
    Investigated diseases:
    Italy